IIT Roorkee Inaugurates Ashok Soota Molecular Medicine Facility at BSBE to Advance Translational Biomedical Research

▴ IIT Roorkee Inaugurates Ashok Soota Molecular Medicine Facility at BSBE to Advance Translational Biomedical Research
State-of-the-art facility to strengthen molecular diagnostics, precision medicine, and translational research.

IIT Roorkee, Uttarakhand and SKAN Bangalore | 17 March 2026 - The Indian Institute of Technology Roorkee (IIT Roorkee) inaugurated the Ashok Soota Molecular Medicine Facility at the Department of Biosciences and Bioengineering (BSBE), marking a significant step in strengthening advanced biomedical research infrastructure aligned with national healthcare priorities and global scientific advancements.

The facility was inaugurated by Shri Ashok Soota, a distinguished Alumnus of IIT Roorkee in the presence of Prof. K. K. Pant, Director, IIT Roorkee, along with faculty members, researchers, and industry representatives.

 Established as a state-of-the-art, integrated platform, the Ashok Soota Molecular Medicine Facility is designed to support drug discovery, biomolecular research, and the development of next-generation diagnostic tools. The facility enables researchers to move from decoding disease mechanisms and identifying biomolecular targets to experimental validation of lead molecules and assay development. By integrating expertise in protein science, molecular and cell biology, structural biology, biophysics, analytical profiling, and advanced imaging, the facility will support high-impact research across critical disease domains, including cancer, neurological disorders, metabolic diseases, and infectious diseases. 

The facility houses advanced instrumentation supporting end-to-end workflows in molecular characterization and translational research, including Automated Protein Purification Systems (AKTA and Biorad/AKTA), HPLC and UPLC systems, GC-MS, Iso-Thermal Calorimeter (ITC), Flow Cytometer, Upright Confocal Microscope, Small-Angle X-ray Scattering (SAXS), Protein Crystallization Robot, CD Spectrometer, High Pressure Homogenizer/Cell Disruptor, and other high-precision analytical platforms. This comprehensive infrastructure significantly strengthens IIT Roorkee’s capability in molecular diagnostics, structural validation, biomolecular interaction studies, and advanced assay development.

Addressing the gathering, Prof. K. K. Pant, Director, IIT Roorkee, said, “The Ashok Soota Molecular Medicine Facility significantly augments IIT Roorkee’s research ecosystem in biosciences and bioengineering. The integration of advanced infrastructure with interdisciplinary expertise will accelerate translational research and contribute meaningfully to national priorities in healthcare innovation, precision medicine, and scientific self-reliance.”

Shri Ashok Soota, distinguished alumnus of IIT Roorkee, stated, “The establishment of this facility underscores the importance of building strong research ecosystems that translate scientific discovery into societal impact. India possesses immense scientific talent, and it is equally critical to provide world-class infrastructure and collaborative platforms to enable innovation at scale. I am proud to see IIT Roorkee strengthening its capabilities in molecular diagnostics, precision medicine, and drug discovery, contributing to healthcare solutions of both national and global relevance.”

Prof. Pravindra Kumar, Head, Institute Instrumentation Center, and Ashok Soota Institute Chair Professor, added, “This facility will serve as a collaborative research platform for faculty, scholars, and industry partners. It enhances our shared research infrastructure and strengthens IIT Roorkee’s capacity to undertake globally competitive, interdisciplinary research in molecular medicine and translational biosciences.”

With this initiative, IIT Roorkee continues to reinforce its commitment to advancing interdisciplinary research, fostering industry collaboration, and contributing to innovation-driven solutions in areas of strategic importance to national and global healthcare systems.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026